{
    "Trade/Device Name(s)": [
        "A1AT Genotyping Test"
    ],
    "Submitter Information": "Progenika Biopharma S.A., a Grifols Company",
    "510(k) Number": "K171868",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063498"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PZH"
    ],
    "Summary Letter Date": "June 20, 2017",
    "Summary Letter Received Date": "June 22, 2017",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5130"
    ],
    "Regulation Name(s)": [
        "Alpha-1-antitrypsin immunological test system"
    ],
    "Analyte Class(es)": [
        "genetic molecular"
    ],
    "Analyte(s)": [
        "SERPINA1 gene",
        "Alpha-1 antitrypsin allelic variants (c.187C>T, c.194T>C, c.226_228delTTC, c.230C>T, c.552delC, c.646+1G>T, c.721A>T, c.739C>T, c.839A>T, c.863A>T, c.1096G>A, c.1130dupT, c.1158dupC, c.1178C>T)"
    ],
    "Specimen Type(s)": [
        "Whole Blood (dry blood spot)",
        "Whole Blood (K2-EDTA)"
    ],
    "Specimen Container(s)": [
        "Dry blood spot",
        "K2-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Luminex 200 instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Polymerase chain reaction (PCR)",
        "Hybridization",
        "Fluorescent conjugate detection",
        "Luminex xMAP technology"
    ],
    "Methodologies": [
        "Multiplex PCR",
        "Oligonucleotide probe hybridization",
        "Genotype analysis software"
    ],
    "Submission Type(s)": [
        "Kit",
        "Software",
        "Reagent",
        "Component"
    ],
    "Document Summary": "FDA 510(k) summary for Progenika A1AT Genotyping Test using multiplex PCR and probe hybridization on Luminex platform to identify 14 SERPINA1 gene variants for alpha-1 antitrypsin deficiency diagnosis.",
    "Indications for Use Summary": "Qualitative PCR and hybridization-based in vitro test to detect and identify 14 SERPINA1 gene variants in genomic DNA from whole blood (DBS or K2-EDTA) as an aid in diagnosing individuals with alpha-1 antitrypsin deficiency (A1ATD), used with clinical findings and other laboratory tests.",
    "fda_folder": "Immunology"
}